Indefinite Delivery Contract SPE2DX15D1114

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, valued at up to $4,999,999.00, runs through December 31, 2025 and was awarded on a single-award basis without any set-aside designation. The task orders under this IDC cover the delivery of critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, and infectious disease prevention. The primary place of performance is Chesterbrook, Pennsylvania. This IDC serves as the primary vehicle for the DLA to efficiently procure essential pharmaceutical and medical supplies to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined contracting mechanism.

In addition to the DLA contract, Amerisourcebergen Drug Corp also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, which covers similar medical products and prescription drugs. These Indefinite Delivery Contracts enable the government to quickly and effectively acquire a comprehensive range of pharmaceutical and medical supplies required to support various federal healthcare programs and facilities.